vs
Side-by-side financial comparison of LandBridge Co LLC (LB) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $35.2M, roughly 1.6× NATIONAL RESEARCH CORP). LandBridge Co LLC runs the higher net margin — 14.2% vs 5.1%, a 9.1% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -4.6%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $6.1M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
LB vs NRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.8M | $35.2M |
| Net Profit | $8.1M | $1.8M |
| Gross Margin | — | — |
| Operating Margin | 60.0% | 13.3% |
| Net Margin | 14.2% | 5.1% |
| Revenue YoY | 55.6% | -4.6% |
| Net Profit YoY | -83.7% | -72.6% |
| EPS (diluted) | $0.24 | $49.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.8M | $35.2M | ||
| Q3 25 | $50.8M | $34.6M | ||
| Q2 25 | $47.5M | $34.0M | ||
| Q1 25 | $44.0M | $33.6M | ||
| Q4 24 | $36.5M | $36.9M | ||
| Q3 24 | $28.5M | $35.8M | ||
| Q2 24 | $26.0M | $35.0M | ||
| Q1 24 | $19.0M | $35.3M |
| Q4 25 | $8.1M | $1.8M | ||
| Q3 25 | $8.1M | $4.1M | ||
| Q2 25 | $7.5M | $-106.0K | ||
| Q1 25 | $6.5M | $5.8M | ||
| Q4 24 | $49.3M | $6.6M | ||
| Q3 24 | $2.7M | $5.7M | ||
| Q2 24 | $-57.7M | $6.2M | ||
| Q1 24 | $10.8M | $6.4M |
| Q4 25 | 60.0% | 13.3% | ||
| Q3 25 | 60.8% | 22.4% | ||
| Q2 25 | 60.0% | 4.7% | ||
| Q1 25 | 57.0% | 25.6% | ||
| Q4 24 | 49.4% | 26.0% | ||
| Q3 24 | 11.2% | 22.3% | ||
| Q2 24 | -197.4% | 25.3% | ||
| Q1 24 | 71.1% | 24.8% |
| Q4 25 | 14.2% | 5.1% | ||
| Q3 25 | 15.9% | 11.9% | ||
| Q2 25 | 15.8% | -0.3% | ||
| Q1 25 | 14.7% | 17.2% | ||
| Q4 24 | 135.2% | 17.8% | ||
| Q3 24 | 9.3% | 15.9% | ||
| Q2 24 | -222.1% | 17.6% | ||
| Q1 24 | 56.7% | 18.0% |
| Q4 25 | $0.24 | $49.58 | ||
| Q3 25 | $0.26 | $0.18 | ||
| Q2 25 | $0.24 | $-0.01 | ||
| Q1 25 | $0.20 | $0.25 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | $-0.04 | $0.24 | ||
| Q2 24 | — | $0.26 | ||
| Q1 24 | — | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.7M | $4.1M |
| Total DebtLower is stronger | $570.7M | — |
| Stockholders' EquityBook value | $340.3M | $14.0M |
| Total Assets | $1.4B | $134.9M |
| Debt / EquityLower = less leverage | 1.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.7M | $4.1M | ||
| Q3 25 | $28.3M | $2.2M | ||
| Q2 25 | $20.3M | $5.3M | ||
| Q1 25 | $14.9M | $2.5M | ||
| Q4 24 | $37.0M | $4.2M | ||
| Q3 24 | $14.4M | $3.5M | ||
| Q2 24 | $24.6M | $485.0K | ||
| Q1 24 | — | $1.7M |
| Q4 25 | $570.7M | — | ||
| Q3 25 | $366.1M | — | ||
| Q2 25 | $370.9M | — | ||
| Q1 25 | $375.5M | — | ||
| Q4 24 | $385.5M | — | ||
| Q3 24 | $242.4M | $48.7M | ||
| Q2 24 | $360.8M | $33.3M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | $340.3M | $14.0M | ||
| Q3 25 | $272.0M | $14.3M | ||
| Q2 25 | $266.4M | $21.3M | ||
| Q1 25 | $217.0M | $29.7M | ||
| Q4 24 | $211.8M | $31.3M | ||
| Q3 24 | $97.2M | $34.6M | ||
| Q2 24 | $296.4M | $40.2M | ||
| Q1 24 | $162.3M | $36.9M |
| Q4 25 | $1.4B | $134.9M | ||
| Q3 25 | $1.1B | $135.7M | ||
| Q2 25 | $1.1B | $141.4M | ||
| Q1 25 | $1.0B | $135.2M | ||
| Q4 24 | $1.0B | $132.5M | ||
| Q3 24 | $689.9M | $131.8M | ||
| Q2 24 | $710.5M | $119.1M | ||
| Q1 24 | — | $120.9M |
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.73× | — | ||
| Q4 24 | 1.82× | — | ||
| Q3 24 | 2.49× | 1.41× | ||
| Q2 24 | 1.22× | 0.83× | ||
| Q1 24 | — | 0.95× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $7.2M |
| Free Cash FlowOCF − Capex | $122.0M | $6.1M |
| FCF MarginFCF / Revenue | 214.9% | 17.2% |
| Capex IntensityCapex / Revenue | 7.5% | 3.2% |
| Cash ConversionOCF / Net Profit | 15.68× | 3.99× |
| TTM Free Cash FlowTrailing 4 quarters | $207.7M | $15.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $7.2M | ||
| Q3 25 | $34.9M | $13.8M | ||
| Q2 25 | $37.3M | $-1.1M | ||
| Q1 25 | $15.9M | $6.6M | ||
| Q4 24 | $67.6M | $6.4M | ||
| Q3 24 | $7.5M | $9.4M | ||
| Q2 24 | $16.0M | $6.8M | ||
| Q1 24 | $17.2M | $12.0M |
| Q4 25 | $122.0M | $6.1M | ||
| Q3 25 | $33.7M | $10.2M | ||
| Q2 25 | $36.1M | $-4.1M | ||
| Q1 25 | $15.8M | $3.7M | ||
| Q4 24 | $66.7M | $1.9M | ||
| Q3 24 | $7.1M | $7.8M | ||
| Q2 24 | $15.7M | $1.5M | ||
| Q1 24 | $17.1M | $7.9M |
| Q4 25 | 214.9% | 17.2% | ||
| Q3 25 | 66.3% | 29.4% | ||
| Q2 25 | 75.9% | -12.2% | ||
| Q1 25 | 36.0% | 10.9% | ||
| Q4 24 | 182.6% | 5.2% | ||
| Q3 24 | 25.1% | 21.8% | ||
| Q2 24 | 60.4% | 4.3% | ||
| Q1 24 | 90.1% | 22.4% |
| Q4 25 | 7.5% | 3.2% | ||
| Q3 25 | 2.3% | 10.4% | ||
| Q2 25 | 2.6% | 8.8% | ||
| Q1 25 | 0.2% | 8.9% | ||
| Q4 24 | 2.7% | 12.0% | ||
| Q3 24 | 1.1% | 4.5% | ||
| Q2 24 | 1.4% | 15.0% | ||
| Q1 24 | 0.5% | 11.7% |
| Q4 25 | 15.68× | 3.99× | ||
| Q3 25 | 4.31× | 3.34× | ||
| Q2 25 | 4.98× | — | ||
| Q1 25 | 2.46× | 1.15× | ||
| Q4 24 | 1.37× | 0.97× | ||
| Q3 24 | 2.80× | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | 1.60× | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
